Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hoya Corp.

Latest From Cipla Europe NV

European Notebook: Sanofi Exiting Toulouse; Job Cuts At Pierre Fabre; Generics Suspended In Four States

The newly formed European Commission sets out plans to improve industrial growth and international trade while leading French pharma companies Sanofi and Pierre Fabre announce plans to trim their R&D workforces. Asian companies in contrast are seeking growth opportunities in Europe, including India’s Cipla and Thailand’s CP Group.

BioPharmaceutical Consumer
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Hoya Corp.
  • Senior Management
  • Hiroshi Suzuki, Pres. & CEO
    Ryo Hirooka, CFO
    Eiichiro Ikeda, COO & CTO
    Augustine Yee, Head, Corp. Dev. & Affairs
  • Contact Info
  • Hoya Corp.
    Phone: (81)
    20F Nittochi Nishishinjuku Bldg., 6-10-1
    Nishi-Shinjuku
    Tokyo, 160-8347
    Japan
Advertisement
Advertisement
UsernamePublicRestriction

Register